Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials.

Pericàs JM, Di Prospero NA, Anstee QM, Mesenbrinck P, Kjaer MS, Rivera-Esteban J, Koenig F, Sena E, Pais R, Manzano R, Genescà J, Tacke F, Ratziu V; EU-PEARL NASH Investigators. Aliment Pharmacol Ther. 2023 Mar 14. doi: 10.1111/apt.17456.